USA - NASDAQ:LITS - US55279B3015 - Common Stock
The current stock price of LITS is 2.45 USD.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABBV | ABBVIE INC | 21.99 | 411.31B | ||
AMGN | AMGEN INC | 13.55 | 159.11B | ||
GILD | GILEAD SCIENCES INC | 15.09 | 144.90B | ||
VRTX | VERTEX PHARMACEUTICALS INC | 24.22 | 105.19B | ||
REGN | REGENERON PHARMACEUTICALS | 12.78 | 61.82B | ||
ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 60.24B | ||
ARGX | ARGENX SE - ADR | 86.01 | 48.80B | ||
ONC | BEONE MEDICINES LTD-ADR | 5.52 | 37.52B | ||
INSM | INSMED INC | N/A | 34.31B | ||
BNTX | BIONTECH SE-ADR | N/A | 25.50B | ||
NTRA | NATERA INC | N/A | 23.13B | ||
BIIB | BIOGEN INC | 9.51 | 22.32B |
MEI Pharma, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical compounds. The company is headquartered in San Diego, California and currently employs 28 full-time employees. The company went IPO on 2003-12-18. The firm's treasury initiative is anchored by Litecoin. The firm has discontinued the clinical development of voruciclib, while certain nonclinical activities related to its drug candidate assets continue to be conducted by it. As part of the review of strategic alternatives, the Company may consider options such as out-licensing opportunities for existing programs and merger and acquisition opportunities.
LITE STRATEGY INC
9920 Pacific Heights Blvd, Suite 150
San Diego CALIFORNIA US
Employees: 28
Phone: 18583697100
The current stock price of LITS is 2.45 USD. The price decreased by -5.77% in the last trading session.
The exchange symbol of LITE STRATEGY INC is LITS and it is listed on the Nasdaq exchange.
LITS stock is listed on the Nasdaq exchange.
LITE STRATEGY INC (LITS) has a market capitalization of 87.37M USD. This makes LITS a Micro Cap stock.
LITE STRATEGY INC (LITS) currently has 28 employees.
LITE STRATEGY INC (LITS) has a resistance level at 2.69. Check the full technical report for a detailed analysis of LITS support and resistance levels.
The Revenue of LITE STRATEGY INC (LITS) is expected to decline by -100% in the next year. Check the estimates tab for more information on the LITS EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
LITS does not pay a dividend.
LITE STRATEGY INC (LITS) will report earnings on 2025-11-10.
The PE ratio for LITE STRATEGY INC (LITS) is 0.92. This is based on the reported non-GAAP earnings per share of 2.67 and the current share price of 2.45 USD. Check the full fundamental report for a full analysis of the valuation metrics for LITS.
The outstanding short interest for LITE STRATEGY INC (LITS) is 6.29% of its float. Check the ownership tab for more information on the LITS short interest.
ChartMill assigns a technical rating of 3 / 10 to LITS.
ChartMill assigns a fundamental rating of 4 / 10 to LITS. While LITS has a great health rating, there are worries on its profitability.
Over the last trailing twelve months LITS reported a non-GAAP Earnings per Share(EPS) of 2.67. The EPS increased by 157.67% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -152.38% | ||
ROE | -162.03% | ||
Debt/Equity | 0 |
For the next year, analysts expect an EPS growth of -339.91% and a revenue growth -100% for LITS